HAWKTAIL — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Georgiamune is a biopharmaceutical company developing targeted immunomodulator drugs that activate or down-modulate immune signaling pathways to treat cancer and autoimmune diseases.
BiotechDeep TechHealthtechGaithersburg, US
Samir N. Khleif(Founder & CEO)Ramy Ibrahim(Chief Medical and Strategy Officer)Mikayel Mkrichyan(Senior Vice President of Science and Discovery)Sarah Sharman(Vice President of IP Legal Affairs)
BoardSean Parker(Director)Elena Viboch(Director)
Co-investorsCatalio Capital Management, LPLauder PartnersPrevail Venture CapitalGeneral CatalystJohnson & Johnson Innovation – JJDC
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.